BIOCON Announces Quarterly Results (4QFY19); Net Profit Down 53.8%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON Announces Quarterly Results (4QFY19); Net Profit Down 53.8%
Fri, 26 Apr

BIOCON has announced its results for the quarter ended March 2019. Here is a detailed performance review of the same:

BIOCON Quarterly Financials

No. of Mths
Qtr. Ending
3
Mar-18*
3
Dec-18*
3
Mar-19*
QoQ ChangeYoY Change
Net SalesRs m11,69515,4087,639-50.4%-34.7%
Other incomeRs m675256139-45.7%-79.4%
TurnoverRs m12,37015,6647,778-50.3%-37.1%
ExpensesRs m9,36511,6016,654-42.6%-28.9%
Gross profitRs m2,3813,865985-74.5%-58.6%
DepreciationRs m9531,167375-67.9%-60.7%
InterestRs m1691866-96.8%-96.4%
Profit before taxRs m1,9342,768743-73.2%-61.6%
TaxRs m40746138-91.8%-90.7%
Profit after taxRs m1,5272,307705-69.4%-53.8%
Gross profit margin%20.425.112.9
Effective tax rate%21.016.75.1
Net profit margin%12.314.79.1
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter fell 34.7% on a year-on-year (YoY) basis. The expenses were down by 28.9% YoY during the same period.
  • The company's operating profit declined by 58.6% YoY during the quarter. Consequently, operating profit margins witnessed a decline and stood at 12.9% in 4QFY19 as against 20.4% in 4QFY18.
  • Depreciation charges declined by 60.7% and finance costs declined by 96.4% YoY, respectively.
  • Other income declined by 79.4% YoY during the quarter.
  • Net profit for the quarter declined by 53.8% YoY. Net profit margins during the quarter declined from 12.3% in 4QFY18 to 9.1% in 4QFY19.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter fell 50.4% on a quarter-on-quarter (QoQ) basis. The expenses were down by 42.6% QoQ during the same period.
  • The company's operating profit declined by 74.5% QoQ during the quarter. Consequently, operating profit margins witnessed a decline and stood at 12.9% in 4QFY19 as against 25.1% in 3QFY18.
  • Net profit for the quarter declined by 69.4% QoQ, while net profit margins declined from 14.7% in 3QFY18 to 9.1% in 4QFY19.

To see how BIOCON has performed over the last eight quarters, please visit here.

BIOCON Share Price Performance

Over the last one year, BIOCON share price has moved up from Rs 663.3 to Rs 619.9, registering a Loss of Rs 43.4 or around 6.5%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 14,464.7 (up 0.2%). Over the last one year it has moved up from 13,930.8 to 14,464.7, a gain of 534 points (up 3.8%).

Overall, the S&P BSE SENSEX is up 13.2% over the year.

Current Valuations

At the current price of Rs 619.9, the price to earnings (P/E) ratio of BIOCON stands at 45.5 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 7.2 times.

Equitymaster requests your view! Post a comment on "BIOCON Announces Quarterly Results (4QFY19); Net Profit Down 53.8%". Click here!

  

Related Views on News

BIOCON Announces Quarterly Results (2QFY20); Net Profit Down 30.5% (Quarterly Result Update)

Nov 1, 2019 | Updated on Nov 1, 2019

For the quarter ended September 2019, BIOCON has posted a net profit of Rs 3 bn (down 30.5% YoY). Sales on the other hand came in at Rs 16 bn (up 19.0% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

BIOCON Announces Quarterly Results (1QFY20); Net Profit Down 11.5% (Quarterly Result Update)

Jul 29, 2019 | Updated on Jul 29, 2019

For the quarter ended June 2019, BIOCON has posted a net profit of Rs 1 bn (down 11.5% YoY). Sales on the other hand came in at Rs 5 bn (down 57.2% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

My Latest Stock Recommendation(Fast Profits Daily)

Jan 10, 2020

The story behind my latest stock recommendation and an important announcement.

Saffron Curtain = Hindutva Rate of Growth?(The Honest Truth)

Jan 8, 2020

Will the Indian economy revert to a sub-3% growth rate?

Bet on These Smallcap Stocks for Success in 2020(Profit Hunter)

Jan 14, 2020

The smallcap rebound finally seems to here... Make sure you aren't too late to make the most of the biggest wealth making opportunity in a decade.

Your Safe Income Options for 2020(Fast Profits Daily)

Jan 9, 2020

What are you safest investing options in 2020 when interest rates fall.

Guess Which Stocks Are Rising at Double the Speed of Sensex(Profit Hunter)

Jan 15, 2020

These stocks can move twice as fast as the Sensex - to take advantage of their money multiplying power get in now as the rally is still just taking shape.. read more to not miss out.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get our special report, Secret to Increasing Your Trading Profits Today Now!
We will never sell or rent your email id.
Please read our Terms

BIOCON SHARE PRICE


Jan 21, 2020 11:25 AM

TRACK BIOCON

COMPARE BIOCON WITH

MARKET STATS